Bilirubin Blood Test Market

By Test Type;

Total Serum Bilirubin (TSB), Direct/Conjugated Bilirubin Test and Indirect/Unconjugated Bilirubin Test

By Product Type;

Consumables and Instruments

By End User;

Hospitals, Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn315112656 Published Date: August, 2025

Bilirubin Blood Test Market Overview

Bilirubin Blood Test Market (USD Million)

Bilirubin Blood Test Market was valued at USD 899.09 million in the year 2024. The size of this market is expected to increase to USD 1,443.74 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.


Bilirubin Blood Test Market

*Market size in USD million

CAGR 7.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.0 %
Market Size (2024)USD 899.09 Million
Market Size (2031)USD 1,443.74 Million
Market ConcentrationMedium
Report Pages382
899.09
2024
1,443.74
2031

Major Players

  • Koninklijke Philips N.V.
  • Beckman Coulter, Inc. (Danaher)
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Drgerwerk AG & Co. KGaA
  • Ginevri
  • Advanced Instruments
  • Reichert, Inc.
  • Instrumentation Laboratory

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Bilirubin Blood Test Market

Fragmented - Highly competitive market without dominant players


The Bilirubin Blood Test Market is evolving through significant technological advancements, with more than 60% of development centered on automated platforms and digital colorimetry readers. These systems enhance efficacy, ensuring repeatable results and reducing processing errors. Reliable bilirubin monitoring is driving dependable growth and boosting lab confidence.

Joint Quality Programs Improving Accuracy
Nearly 50% of test enhancements are a result of collaboration and partnerships among diagnostics companies, hospital labs, and neonatal care units. These strategies standardize calibration procedures, optimize reagents, and validate test accuracy. Such coordinated efforts are enabling broader expansion of reliable bilirubin testing in critical care.

Portable Devices Expanding Point-of-Care Testing
Over 55% of innovation focuses on innovation in handheld bilirubinometers and strip-based diagnostics. These point-of-care tests offer quick bedside results, require minimal sample volumes, and support at-home screening. Enhanced portability and convenience are strengthening the market’s future outlook and driving sustained growth in decentralized care.

Connected Platforms Supporting Data Insights
With over 50% of facilities using LIMS-connected devices and real-time monitoring dashboards, bilirubin testing is becoming more efficient. These systems offer alerts, instrument performance tracking, and result analytics. Integrating digital platforms with test technology highlights essential technological advancements, enabling sustained growth and a promising future outlook.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Test Type
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Bilirubin Blood Test Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Neonatal screening programs

        2. Growing healthcare infrastructure

        3. Rising awareness about early diagnosis of jaundice

        4. Government initiatives for healthcare accessibility

      2. Restraints

        1. High cost associated with bilirubin testing devices

        2. Limited availability of skilled healthcare professionals

        3. Challenges in accurate diagnosis

        4. Cultural beliefs affecting acceptance of neonatal screening

      3. Opportunities
        1. Research and development for novel bilirubin

        2. Partnerships and collaborations for market penetration

        3. Growing focus on personalized medicine

        4. Integration of artificial intelligence in bilirubin testing

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Bilirubin Blood Test Market, By Test Type, 2021 - 2031 (USD Million)
      1. Total Serum Bilirubin (TSB)
      2. Direct/Conjugated Bilirubin Test
      3. Indirect/Unconjugated Bilirubin Test
    2. Bilirubin Blood Test Market, By Product Type, 2021 - 2031 (USD Million)
      1. Consumables
      2. Instruments
    3. Bilirubin Blood Test Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
    4. Bilirubin Blood Test Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Koninklijke Philips N.V.
      2. Beckman Coulter, Inc. (Danaher)
      3. Thermo Fisher Scientific Inc.
      4. Randox Laboratories Ltd.
      5. F. Hoffmann-La Roche AG
      6. Drgerwerk AG & Co. KGaA
      7. Ginevri
      8. Advanced Instruments
      9. Reichert, Inc.
      10. Instrumentation Laboratory
  7. Analyst Views
  8. Future Outlook of the Market